- Our Team
- For Patients
- Treatments & Services
- Medical Professionals
Ovarian
Clinical Trial Search
Trial Protocol ID
USOR 24112_ TORL123-002
Investigator
Carol Tweed, MD
A Phase 2 Study Evaluating The Efficacy And Safety Of TORL-1-23 In Women With Advanced Platinum Resistant Epithelial Ovarian Cancer (Including Primary Peritoneal And Fallopian Tube Cancers) Expressing Claudin 6 (CLND6) (TORL123-002)
Trial Protocol ID
USOR 21270_ZN-c3-005 *RIT* on HOLD effective 09/20/2024
Investigator
Syed Shahid Mahmood, MD
A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Subjects with High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Trial Protocol ID
USOR 21271_ZN-c3-004 | GOG 3065
Investigator
Jeanine L Werner, MD
A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Adult Women with Recurrent or Persistent Uterine Serous Carcinoma (ZN-c3-004 | GOG 3065)